CLINICAL TRIALS PROFILE FOR CHLORPROPAMIDE
✉ Email this page to a colleague
All Clinical Trials for CHLORPROPAMIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00004363 ↗ | Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus | Completed | Northwestern University | 1995-12-01 | OBJECTIVES: I. Determine whether diverse mutations of the vasopressin-neurophysin II (AVP-NPII) gene cause autosomal dominant familial neurohypophyseal diabetes insipidus by directing the production of an abnormal preprohormone. II. Determine whether the AVP-NPII gene-directed preprohormone accumulates and destroys magnocellular neurons because it cannot be folded and processed efficiently. | |
| NCT00004363 ↗ | Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus | Completed | National Center for Research Resources (NCRR) | 1995-12-01 | OBJECTIVES: I. Determine whether diverse mutations of the vasopressin-neurophysin II (AVP-NPII) gene cause autosomal dominant familial neurohypophyseal diabetes insipidus by directing the production of an abnormal preprohormone. II. Determine whether the AVP-NPII gene-directed preprohormone accumulates and destroys magnocellular neurons because it cannot be folded and processed efficiently. | |
| NCT00881543 ↗ | "Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients" | Completed | University of Sao Paulo | N/A | 2009-06-01 | The purpose of this study is to demonstrate the secretion of glucose, insulin, glucagon, C-peptide and lipid profile after isocaloric diets with different nutritional compounds (fat, protein and carbohydrate food) in drug näive tipo 2 patients. |
| NCT00881543 ↗ | "Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients" | Completed | University of Sao Paulo General Hospital | N/A | 2009-06-01 | The purpose of this study is to demonstrate the secretion of glucose, insulin, glucagon, C-peptide and lipid profile after isocaloric diets with different nutritional compounds (fat, protein and carbohydrate food) in drug näive tipo 2 patients. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CHLORPROPAMIDE
Condition Name
Clinical Trial Locations for CHLORPROPAMIDE
Trials by Country
Clinical Trial Progress for CHLORPROPAMIDE
Clinical Trial Phase
Clinical Trial Sponsors for CHLORPROPAMIDE
Sponsor Name
| Sponsor Name for CHLORPROPAMIDE | |
| Sponsor | Trials |
| Canadian Institutes of Health Research (CIHR) | 3 |
| Drug Safety and Effectiveness Network, Canada | 3 |
| Canadian Network for Observational Drug Effect Studies, CNODES | 3 |
| [disabled in preview] | 1 |
| This preview shows a limited data set Subscribe for full access, or try a Trial | |
